ConductScience.org, home

Paper5337399

Studies on bleomycin.

Umezawa H and 3 others. Cancer, 1967. Cited by 191 papers, by iCite.

Cite this record

ConductScience Library. Studies on bleomycin. Papers, record 5337399. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5337399

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Umezawa HH
2Ishizuka MM
3Maeda KK
4Takeuchi TT

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibiotics, AntineoplasticMajor topic
Carcinoma, Ehrlich TumorMajor topic
Culture TechniquesMajor topic
Escherichia coliMajor topic
Animals
DNA, Bacterial
Dogs
HeLa Cells
Mice
Rabbits
Sarcoma 180

Source PubMed

Download CSV of topics

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 191 citations.

PMIDTitleJournalYearIn PapersSource
42613079Murine models of pulmonary fibrosis: mechanisms, limitations and translational insights.Eur Respir Rev2026https://conductscience.org/library/papers/42613079PubMed
41599636FAPI Tracer en Vogue: Evaluating [68Ga]Ga-DATA5m.SA.FAPi for Molecular Imaging of Pulmonary Fibrosis.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41599636PubMed
37725153Baicalin and lung diseases.Naunyn Schmiedebergs Arch Pharmacol2024https://conductscience.org/library/papers/37725153PubMed
36834561Immune Mechanisms of Pulmonary Fibrosis with Bleomycin.Int J Mol Sci2023https://conductscience.org/library/papers/36834561PubMed
36176753Electrochemotherapy using thin-needle electrode improves recovery in feline nasal planum squamous cell carcinoma - a translational model.Cancer Drug Resist2022https://conductscience.org/library/papers/36176753PubMed
36139200Retrospective Evaluation of a Combination of Carboplatin and Bleomycin for the Treatment of Canine Carcinomas.Animals (Basel)2022https://conductscience.org/library/papers/36139200PubMed
34943779Mesenchymal Stromal Cells for the Treatment of Interstitial Lung Disease in Children: A Look from Pediatric and Pediatric Surgeon Viewpoints.Cells2021https://conductscience.org/library/papers/34943779PubMed
34683897Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations.Pharmaceutics2021https://conductscience.org/library/papers/34683897PubMed
34028755Mouse Models of Skin Fibrosis.Methods Mol Biol2021https://conductscience.org/library/papers/34028755PubMed
31935268Optimization of cytotoxic activity of Nocardia sp culture broths using a design of experiments.PLoS One2020https://conductscience.org/library/papers/31935268PubMed
30594446Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma.Clin Lymphoma Myeloma Leuk2019https://conductscience.org/library/papers/30594446PubMed
29740320Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.Front Pharmacol2018https://conductscience.org/library/papers/29740320PubMed
29172151Oxidative stress-driven pulmonary inflammation and fibrosis in a mouse model of human ataxia-telangiectasia.Redox Biol2018https://conductscience.org/library/papers/29172151PubMed
28769196PULMONARY LESIONS ASSOCIATED WITH BLEOMYCIN THERAPY IN MALIGNANCIES.Med J Armed Forces India1994https://conductscience.org/library/papers/28769196PubMed
28677860Molecular Magnetic Resonance Imaging of Lung Fibrogenesis with an Oxyamine-Based Probe.Angew Chem Int Ed Engl2017https://conductscience.org/library/papers/28677860PubMed
24985397IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice.J Allergy Clin Immunol2014https://conductscience.org/library/papers/24985397PubMed
24583879Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease.Am J Physiol Lung Cell Mol Physiol2014https://conductscience.org/library/papers/24583879PubMed
19129758Pulmonary fibrosis: pathogenesis, etiology and regulation.Mucosal Immunol2009https://conductscience.org/library/papers/19129758PubMed
17936056The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?Int J Biochem Cell Biol2008https://conductscience.org/library/papers/17936056PubMed
16752933Dose adaptation of antineoplastic drugs in patients with liver disease.Drug Saf2006https://conductscience.org/library/papers/16752933PubMed

See all 41 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5337399

GET https://conductscience.org/api/papers/v1/5337399/cited_by?page=2